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h hypertropi ! cardiomyopathy was probably first 
described in the lot MOs and early I 
C;erman authors, it was not until 1958 that 
made the first systematic description of t 
virish Nctrrt Journa/. Since then, a multitude of reports 
have been published on all aspects of the syndrome. In the 
past decade, because of their apprrrent association with 
syncop and sudden death (2-IO), attention has been de- 
voted to the rhythm disturbances that are frequently present 
in hy~~~phic cardiomyopathy. Nonsustained ventricular 
tachycardin on ambulatory electrocardiography is more fre- 
quent in patients who die suddenly (9). In addition, other 
feature%, including young age, a family history of sudden 
death amI previous syncopc, have been identified as risk 
factors for sudden death (7,9,11,12). Nienaber et al. (13). in 
this issue of the Journal, note that, although these factors 
associated with sudden death have been identified, predic- 
tors of syncope in hypertrophic cardiomyopathy have not 
been analyzed. 
patients without syncope but with s~ntaneo~s 
ith use of all discriminate varia- 
risk, three variables were found 
to be i~de~nd~ntly significant: I) age 930 years (the young. 
eSt patient Was 21 years, the oldest 47 years): 21 left 
i+om the Sectban cif Cdhlqy. G&ersity of Arizona College of 
Section of Cardiology. Veterans Affairs Medical Center. 
- Robert 0. Brandenburg. MD. Section ofCardiology. 
veterans A@&s Medical Center, Tucscn. Arizona 85723. 
ventricular end-diastolic volume index <60 ml/m’; and 31 a 
Lown grade 1Vb pattern of ventricular arrhythmia on 72 h 
electrocardiographic (FAX) Holter monitoring. 
The combined occurrence of all variables kad a 
remarkable 100% sensitivity and speci in ideatify~~g the 
eight patients with syncopal events. There was no gender 
nce in f~nctioaa~ class 
differences in the i~lci~c~ce of in 
sustained vsntricular ~~rrhytt~~l~~~. 
hypertrophy score, septal thicknc 
ejection fraction was 
and end-systolic vol 
er in group I, whereas end-diastolic 
indexes were sig~~~cant~y lower. 
quently, this study (13) appears to separate low iisk from 
high risk patients an the basis af the close association 
bincs a young age with nonsustained ventricular tachyca~ia 
and severe left ventricular hypertropby with a small left 
ventricular filling volume. This combination allows the pos- 
sibility of a rapid decrease in cardiac o~tpMt, with ~es~~ta~t 
ssible sudden death. The results 
ing, but do support and enhaa 
studies of suti%en death by analyzing the predictors of 
syncope. Patients with extensive hy~~~phy have been 
reported to be more symptomatic, with impaired relaxation 
and delayed ventricular filling, a higher incidence of atrial 
and ventricular arrhythmias and a poorer prognosis (14). 
Wigle et al. (IS) observed a correlation between the degree 
and location of hypertrophy by echocardiogram and the 
incidence of ventricular tachycardia. The association of 
youthful age and sudden death has been well documented 
(7. 
ot is CPW risk proJie in older pafients-adults >3Q 
yem 0.f qe? seventy-two hour monitoring has 
the most useful single tool in the tion of sudden d 
with a sensitivity of 69% and a specificity of 80%. The result; 
of ECG monjto~ng of 
tional Institutes of Healt 
in London disclosed I3 sudden deaths in 3 years (3,43. Nine 
of the I3 patients had nonsustained ventricular tachycardia, 
and the 4 without ventricular tachycardia were monitored for 
0735-1097/90/%3.50 
were hi~be~ in patients with ventricu- 
survived than in those who died sud- 
aired ventricular 
corroborate these findings are not clear, but differences in 
pattent selection may 
The identification of high risk patients with hv~ertro~hi~ 
cardiomyopathy with signal-averaged electr~~ardio~ra~hy is 
ore recent approach to the 
issue of the Journal, stu 
trophic cardiomyopathy and 50 age- and bender-mat~l~ed 
control subjects. There was a significant association be 
the presence of ~o~sustaiaed ve~tri~M~ar tachycardia 
ECC monitoring and the abnor al simian-averaged ECG. 
Eight of 17 of the patients with nonsustained ventricular 
tachycardia had an abnormal signal-averaged ECG, and 6 of 
7 of those with more than three episodes of nons 
cardia per 24 h bad signal-avera 
four patients with a history o 
EGG; two 
al-averaged 
een resuscitated from ventric- 
17) comments about the limi- 
tations of their study should be noted. 1) There are too few 
patients, especially with cardiac arrest; 2) the high-pass filter 
electrical stimulation 
deeding this subset at 
as high risk by additional studies, treatment at 
time is likely to involve ~miod~rone, im 
automatic defibrillator, or both. The ro 
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